Wednesday, February 15, 2006

Health Canada Endorsed Important Safety Information on Octreotide Acetate Omega

From Health Canada:
Omega Laboratories, Ltd has initiated a Class I recall of Octreotide Acetate Omega 500 μg/mL. Some vials of Octreotide Acetate Omega 500 μg/mL Lot 5J970 might contain FLUPHENAZINE 100 mg/mL as a result of a labelling error during the manufacturing process.

Fluphenazine is an antipsychotic medication used to treat schizophrenia and psychotic symptoms such as hallucinations, delusions, and hostility. Fluphenazine is intended to be administered intramuscularly or subcutaneoulsy and should not be administered intravenously as is intended for Octreotide Acetate. ...more

No comments: